|
295 PSNC chairman:
pharmacy’s confidence is shaken Community pharmacy’s confidence has been shaken by the Government’s failure to develop new advanced services, and investment made by pharmacy contractors has gone unrewarded. Chris Hodges, Pharmaceutical Services Negotiating Committee chairman, was to make these points at the committee’s annual dinner this week, after The
Journal went to press. Health minister Dawn Primarolo was due to attend the dinner in London
PJ 2008;280:295
Full Text
295 Lansley tells of category M “boom
and bust” Greater transparency is needed in pharmacy reimbursement, shadow health secretary Andrew Lansley argues in a letter to The Journal this week. Large overpayments and subsequent cuts in Category M prices have led to a “boom and bust” pattern that is in no one’s interests, he writes
PJ 2008;280:295
Full Text
295 Oral contraception PGD starts in Manchester Pharmacy
sexual health services in Manchester have been relaunched with the addition of
a patient group direction (PGD) for supplying oral contraception
PJ 2008;280:295
Full Text
295 Banksy artwork appears on London pharmacy
wall Artwork by graffiti artist Banksy on the wall
of an Islington pharmacy, London
PJ 2008;280:295
Full Text
295 Revised Society election details Amended
information about pharmacists seeking election to the Royal Pharmaceutical Society’s
Council has been issued by the Society
PJ 2008;280:295
Full Text
295 Budget In
his Budget statement made on 12 March 2008, the Chancellor of the Exchequer said
that since 1997 spending on the NHS has almost doubled in real terms
PJ 2008;280:295
Full Text
296 Prescription charge rises by 25p to £7.10 in England Prescription charges in England are to rise by 25p to £7.10 per item on 1 April 2008
PJ 2008;280:296
Full Text
296 Former pharmacist fights confiscation order Former pharmacist Mohammed Shabir, of Wigton Lane, Leeds, who was jailed after defrauding the NHS of £464 is fighting a £200,000 confiscation order imposed by the High Court
PJ 2008;280:296
Full Text
296 MP says nursing regulator is fundamentally
dysfunctional Criticism of the Nursing and Midwifery
Council this week is to result in intervention by the Council for Healthcare
Regulatory Excellence and the Charity Commission
PJ 2008;280:296
Full Text
296 Low volume concerns raised Concerns about losing the protected professional allowance for low-volume pharmacies, particularly in view of the possible impact of Lord Darzi’s proposed polyclinics, were raised at the Pharmaceutical Services Negotiating Committee’s local pharmaceutical committee conference in London this week
PJ 2008;280:296
Full Text
297 Law change to force companies
to report all ADRs Legislative changes that will
force pharmaceutical companies to report adverse drug events promptly, regardless
of the source, will be introduced in the UK by the end of the year after a decision
not to prosecute GlaxoSmithKline for allegedly withholding important safety data
from its clinical trials on Seroxat (paroxetine) in children
PJ 2008;280:297
Full Text
297 Boots refers two-thirds of PGD clients to
their GPs referral rates are high for customers
attending patient group direction (PGD) programmes for erectile dysfunction and
weight management run by Boots The Chemists
PJ 2008;280:297
Full Text
297 Reckitt accused of hindering competition Reckitt
Benckiser has been accused of delaying the introduction of generic alginate compound
products as alternatives to Gaviscon by impeding the publication of a generic
name and by slowing down the introduction of a monograph by the British Pharmacopoeia
Commission
PJ 2008;280:297
Full Text
298 Health tests need to be
evaluated Diagnostic health tests should be evaluated
and regulated in a similar way to medicines, according to a report published
this week
PJ 2008;280:298
Full Text
298 Pharmacies not protected by anti-violence
provisions for NHS Community pharmacists will not
be given the same level of protection from abusive patients as hospital-based
health staff
PJ 2008;280:298
Full Text
298 Hearts ageing faster Hearts are ageing faster than they should, with the average middle-aged adult’s heart having the characteristics of a heart five years’ older than the chronological age of its owner, an analysis of heart health checks by Lloydspharmacy suggests
PJ 2008;280:298
Full Text
298 UniChem returns to BAWP UniChem
has rejoined the British Association of Pharmaceutical Wholesalers as a full
member, it was announced this week
PJ 2008;280:298
Full Text
298 New chief executive for AIMp Colin
Baldwin has been appointed chief executive of the Association of Independent
Multiple Pharmacies (AIMp)
PJ 2008;280:298
Full Text
299 SMC approves infliximab
for child Crohn’s disease Infliximab (Remicade) can be used in Scotland for treatment of paediatric patients with severe active Crohn’s disease, the Scottish Medicines Consortium has decided in its latest round of appraisals
PJ 2008;280:299
Full Text
299 PPRS renegotiation used as reason to limit
comment on Health Select Committee report Renegotiation
of the Pharmaceutical Price Regulation Scheme is being used by the Government
as a reason for not commenting on a Parliamentary recommendation that the National
Institute for Health and Clinical Excellence should assess all new medicines
for cost-effectiveness when they are launched
PJ 2008;280:299
Full Text
299 Tell parents fever is natural response to
infection, says DTB Parents and carers should be reassured that fever is a natural response to infection and may help combat infections, this month’s Drug
and Therapeutics Bulletin recommends
PJ 2008;280:299
Full Text
299 Scottish contractors to receive one-off
public health service payment Community pharmacy contractors in Scotland are to receive a one-off supplementary payment of almost £950 next month for work already carried out as part of tier two of the public health service, which involves displaying public health campaign material in the window of their pharmacies
PJ 2008;280:299
Full Text
300 Novel vaccine reduces
BP by targeting angiotensin II Targeting angiotensin II with a virus-derived vaccine — CYT006-AngQb — has been shown to reduce hypertension in a study published last week. However, the authors of an accompanying editorial raise concerns about the safety of circulating angiotensin II antibodies
PJ 2008;280:300
Full Text
300 Patient safety campaign will kick off in
July A patient safety campaign to reduce harm and
save lives in the NHS in England is to be launched in July 2008
PJ 2008;280:300
Full Text
300 School of Pharmacy images among Wellcome
winners Scientists working at the School of Pharmacy,
University of London, have produced five award-winning colour-enhanced scanning
electron micrographs in the Wellcome Image Awards 2008 (previously the Biomedical
Image Awards)
PJ 2008;280:300
Full Text
300 Goldshield reaches settlement with Scottish
Government Goldshield — one of the generic medicine suppliers accused of illegal price fixing — has reached a settlement with the Scottish Government. A similar agreement was reached with the English Department of Health last year
PJ 2008;280:300
Full Text
301 Study supports use of
aromatase inhibitors after tamoxifen use ends Women
who finished tamoxifen treatment for breast cancer several years ago may still
benefit from taking letrozole to reduce their risk of recurrence further, according
to the lead researcher of an international study
PJ 2008;280:301
Full Text
301 Gwent pharmacies called on to help raise
awareness of illegal dealing of medicines Pharmacy
customers in Gwent are being asked to pass on any information they have about
individuals involved in dealing prescription medicines and illicit drugs
PJ 2008;280:301
Full Text
301 Novartis reports everolimus success Investigation of everolimus — also known as RAD001 — has been stopped early by Novartis after the primary endpoint of its study was successfully met
PJ 2008;280:301
Full Text
301 Broccoli sprouts and bladder cancer Extract
of broccoli sprouts (pictured) could help to protect against bladder cancer,
a rodent study suggests
PJ 2008;280:301
Full Text
301 Lilly axes inhaled insulin Eli Lilly and Company has terminated its inhaled insulin programme — AIR Insulin — a joint venture with Alkermes Inc
PJ 2008;280:301
Full Text
301 New anticancer treatment proposed Scientists
have designed a compound to protect a protein that normally helps suppress tumours
but that is inactivated in almost all human cancers
PJ 2008;280:301
Full Text |
The
Pharmaceutical Journal